<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://teaching.ncl.ac.uk/bms/wiki//api.php?action=feedcontributions&amp;feedformat=atom&amp;user=170109781</id>
	<title>The School of Biomedical Sciences Wiki - User contributions [en]</title>
	<link rel="self" type="application/atom+xml" href="https://teaching.ncl.ac.uk/bms/wiki//api.php?action=feedcontributions&amp;feedformat=atom&amp;user=170109781"/>
	<link rel="alternate" type="text/html" href="https://teaching.ncl.ac.uk/bms/wiki/index.php/Special:Contributions/170109781"/>
	<updated>2026-04-14T23:53:09Z</updated>
	<subtitle>User contributions</subtitle>
	<generator>MediaWiki 1.44.0</generator>
	<entry>
		<id>https://teaching.ncl.ac.uk/bms/wiki//index.php?title=Pre_Initiation_Complex&amp;diff=21720</id>
		<title>Pre Initiation Complex</title>
		<link rel="alternate" type="text/html" href="https://teaching.ncl.ac.uk/bms/wiki//index.php?title=Pre_Initiation_Complex&amp;diff=21720"/>
		<updated>2018-10-25T16:09:47Z</updated>

		<summary type="html">&lt;p&gt;170109781: Add content, links and some references&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;In [[Eukaryotes|eukaryotic]] [[Gene|gene]] expression the Pre Initiation Complex (PIC) mediates the binding between the [[Genome|genome]]&#039;s promoter and [[RNA polymerase|RNA polymerase]]. Each type of RNA polymerase has a different PIC&amp;lt;ref&amp;gt;Cassimeris,L. et al., 2007; p219 Lewin&#039;s cells. 2nd ed. Sudbury: Jones and Bartlett.&amp;lt;/ref&amp;gt;. Assembly of the PIC&amp;lt;ref&amp;gt;Sainsburys S, Bernecky C, Cramer P. Structural basis of transcription initiation by RNA polymerase II. Nature Review Molecular Cell Biology. 2015; 16:129-43.&amp;lt;/ref&amp;gt; is required for initiating transcription. General transcription factors and RNA polymerase join together at the promoter, forming the PIC&amp;lt;ref&amp;gt;Lodish, H. (2016). Molecular cell biology. New York : W.H. Freeman Macmillan Learning. 2016.&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
== Subunits  ==&lt;br /&gt;
&lt;br /&gt;
The complexity of PIC varies between the types of eukaryotic [[Rna polymerases in eukaryotes|RNA polymerase]]. For [[DNA polymerase I|polymerases I]] and [[Polymerase III|III]] the complex consists of only a few subunits. &lt;br /&gt;
&lt;br /&gt;
For [[RNA polymerase II|polymerase II]] the PIC is far more complex. It consists of 6 [[General Transcription Factors|General Transcription Factors]] (GTF). [[TFIID|TFIID]] is the core recognition protein. It&amp;amp;nbsp;is made up of TATA binding protein (TBP) and TBP associated factor (TAF). TBP binds to the [[Tata box|TATA box]], initiating the assembly of PIC. [[TFIIA|TFIIA]]&amp;amp;nbsp;and [[TFIIB|TFIIB]] will then join. TFIIA&amp;amp;nbsp;stabilizes the binding complex while TFIIB helps recruit [[RNA_polymerase_II|RNA polymerase II]]. TFIIB interacts directly with&amp;amp;nbsp;[[RNA polymerase II|RNA polymerase II]] which has [[TFIIF|TFIIF]] attached to it. This allows [[TFIIE|TFIIE]] and finally [[TFIIH|TFIIH]] to bind. TFIIH has [[Helicase|helicase]] activity and starts seperating the strands at the start site, allowing the formation of an [[Open_complex|open complex]]. This process is known as promoter melting and it requires [[ATP hydrolysis|ATP-hydrolysis]]. TFIIH also contains one of the [[Kinase|kinases]] that phosphorylates the [[C-terminal domain|C-terminal domain]]&amp;amp;nbsp;(CTD)&amp;amp;nbsp;of RNA polymerase II. [[Phosphorylation|Phosphrylation]] of CTD is essential for the transition from intiation to elongation.&amp;amp;nbsp;When all GTFs and RNA polymerase II are recruited at the promoter, the assembly of PIC is complete. &lt;br /&gt;
&lt;br /&gt;
However, initiating the assembly of PIC on a TATA-less promoter (promoter without TATA box but other core promoter elements) requires TAFs which responds to the activators.&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
=== References  ===&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references /&amp;gt;&amp;lt;references /&amp;gt;&amp;lt;references /&amp;gt;&lt;/div&gt;</summary>
		<author><name>170109781</name></author>
	</entry>
	<entry>
		<id>https://teaching.ncl.ac.uk/bms/wiki//index.php?title=Chemotroph&amp;diff=20484</id>
		<title>Chemotroph</title>
		<link rel="alternate" type="text/html" href="https://teaching.ncl.ac.uk/bms/wiki//index.php?title=Chemotroph&amp;diff=20484"/>
		<updated>2017-12-06T12:48:53Z</updated>

		<summary type="html">&lt;p&gt;170109781: added and removed links, added text and references&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;An [[Organism|organism]] whose primary energy source&amp;amp;nbsp;is from chemical reactions. They obtain their energy&amp;amp;nbsp;by&amp;amp;nbsp;oxidising [[Organic compound|organic]] or [[Inorganic compound|inorganic compounds]].&amp;amp;nbsp;They can also be known as chemoautotrophs and chemoheterotrophs&amp;lt;ref&amp;gt;Biology-online.org [internet] [cited 2015 Dec 2] Available from: http://www.biology-online.org/dictionary/Chemotroph&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
==== Chemoautotrophs ====&lt;br /&gt;
&lt;br /&gt;
Chemoautotrophs&amp;lt;ref&amp;gt;Gargaud M, Irvine W, Amils R, Cleaves H, Pinti D, Quintanilla J, Rouan D, Spohn T, Viso M and Tirard S. cyclopedia of astrobiology. 2nd Ed: Springer. 2015&amp;lt;/ref&amp;gt; use inorganic carbon dioxide(CO&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;) as their carbon source. Chemolithographs are commonly known chemoautographs that use inorganic compounds such as ferrous iron, hydrogen, hydrogen sulfide, sulphur and ammonia to generate energy. &amp;lt;br&amp;gt;All known chemoautotrophs are found to be prokaryotes that belongs to the [[Bacteria|bacteria ]]and [[Archaea|archaea ]]domains.&amp;lt;br&amp;gt;They are found in extreme habitat such as deep sea vents and highly acidic environments.&amp;lt;br&amp;gt;An example of a chemoautotroph is the &#039;&#039;Sulfolobus acidocaldarius&#039;&#039; found in highly acidic hot springs in US Yellowstone National Park&amp;lt;ref&amp;gt;Microbewiki. Sulfolobus acidocaldarius. 2010 [cited 6/12/17]; Available from: https://microbewiki.kenyon.edu/index.php/Sulfolobus_acidocaldarius&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
==== Chemoheterotrophs&amp;lt;br&amp;gt; ====&lt;br /&gt;
&lt;br /&gt;
Chemoheterotrophs&amp;lt;ref&amp;gt;Gargaud M, Irvine W, Amils R, Cleaves H, Pinti D, Quintanilla J, Rouan D, Spohn T, Viso M and Tirard S. cyclopedia of astrobiology. 2nd Ed: Springer. 2015&amp;lt;/ref&amp;gt; use reduced organic compounds as their energy and carbon source. It is usually known as [[Heterotroph|heterotrophs]].&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;sup&amp;gt;&amp;lt;/sup&amp;gt;&lt;br /&gt;
&lt;br /&gt;
=== References&amp;lt;br&amp;gt; ===&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references /&amp;gt;&amp;lt;references /&amp;gt;&amp;lt;references /&amp;gt;&lt;/div&gt;</summary>
		<author><name>170109781</name></author>
	</entry>
	<entry>
		<id>https://teaching.ncl.ac.uk/bms/wiki//index.php?title=Oseltamivir&amp;diff=19556</id>
		<title>Oseltamivir</title>
		<link rel="alternate" type="text/html" href="https://teaching.ncl.ac.uk/bms/wiki//index.php?title=Oseltamivir&amp;diff=19556"/>
		<updated>2017-12-05T00:21:53Z</updated>

		<summary type="html">&lt;p&gt;170109781: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Oseltamivir is an [[Influenza|influenza]] [[Antiviral medication|antiviral medication]] which is taken orally. It is often sold under the brand name &amp;quot;Tamiflu&amp;quot;&amp;lt;ref&amp;gt;Omudhome Ogbru P. oseltamivir, Tamiflu: Drug Facts, Side Effects, and Dosing. MedicineNet. [cited 3 December 2017]. Available from: https://www.medicinenet.com/oseltamivir/article.htm&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
It is a [[Neuraminidase|neuraminidase]] inhibitor&amp;lt;ref&amp;gt;PubChem. Oseltamivir. 2017 [cited 5/12/17];&lt;br /&gt;
Available from: https://pubchem.ncbi.nlm.nih.gov/compound/oseltamivir#section=Top&amp;lt;/ref&amp;gt;. It blocks the [[Active site|active sites]] of neuraminidases, which are [[Enzyme|enzymes]] on the surface of influenza [[Viruses|viruses]] that cleave sialic acid, and prevents the viruses from entering the host cells. It also prevents the release of newly assembled influenza viruses from the host cells. &lt;br /&gt;
&lt;br /&gt;
=== &#039;&#039;&#039;Structure of oseltamivir&#039;&#039;&#039;  ===&lt;br /&gt;
&lt;br /&gt;
=== [[Image:Structure of oseltamivir.png]]  ===&lt;br /&gt;
&lt;br /&gt;
Fig. 1: Structure of oseltamivir&amp;lt;ref&amp;gt;ChemIDplus. Oseltamivir. 2017 [cited 5/12/17];&lt;br /&gt;
Available from: https://chem.nlm.nih.gov/chemidplus/name/oseltamivir&amp;lt;/ref&amp;gt;&amp;amp;nbsp;&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
Oseltamivir is an acetamido cyclohexene and its structure is homologous to sialic acid. &lt;br /&gt;
&lt;br /&gt;
Influenza viruses use sialic acid as receptors for entering the host cells.&amp;amp;nbsp; &lt;br /&gt;
&lt;br /&gt;
=== References  ===&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references /&amp;gt;&amp;lt;references /&amp;gt;&amp;lt;references /&amp;gt;&lt;/div&gt;</summary>
		<author><name>170109781</name></author>
	</entry>
	<entry>
		<id>https://teaching.ncl.ac.uk/bms/wiki//index.php?title=Oseltamivir&amp;diff=19555</id>
		<title>Oseltamivir</title>
		<link rel="alternate" type="text/html" href="https://teaching.ncl.ac.uk/bms/wiki//index.php?title=Oseltamivir&amp;diff=19555"/>
		<updated>2017-12-05T00:21:01Z</updated>

		<summary type="html">&lt;p&gt;170109781: Added text and reference&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Oseltamivir is an [[Influenza|influenza]] [[Antiviral medication|antiviral medication]] which is taken orally. It is often sold under the brand name &amp;quot;Tamiflu&amp;quot;&amp;lt;ref&amp;gt;Omudhome Ogbru P. oseltamivir, Tamiflu: Drug Facts, Side Effects, and Dosing. MedicineNet. [cited 3 December 2017]. Available from: https://www.medicinenet.com/oseltamivir/article.htm&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
It is a [[Neuraminidase|neuraminidase]] inhibitor&amp;lt;ref name=&amp;quot;3&amp;quot;&amp;gt;PubChem. Oseltamivir. 2017 [cited 5/12/17];&lt;br /&gt;
Available from: https://pubchem.ncbi.nlm.nih.gov/compound/oseltamivir#section=Top&amp;lt;/ref&amp;gt;. It blocks the [[Active_site|active sites]] of neuraminidases, which are [[Enzyme|enzymes]] on the surface of influenza [[Viruses|viruses]] that cleave sialic acid, and prevents the viruses from entering the host cells. It also prevents the release of newly assembled influenza viruses from the host cells.&lt;br /&gt;
&lt;br /&gt;
=== &#039;&#039;&#039;Structure of oseltamivir&#039;&#039;&#039; ===&lt;br /&gt;
&lt;br /&gt;
=== [[Image:Structure_of_oseltamivir.png]] ===&lt;br /&gt;
&lt;br /&gt;
Fig. 1: Structure of oseltamivir&amp;lt;ref name=&amp;quot;2&amp;quot;&amp;gt;ChemIDplus. Oseltamivir. 2017 [cited 5/12/17];&lt;br /&gt;
Available from: https://chem.nlm.nih.gov/chemidplus/name/oseltamivir&amp;lt;/ref&amp;gt;&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
Oseltamivir is an acetamido cyclohexene and its structure is homologous to sialic acid.&lt;br /&gt;
&lt;br /&gt;
Influenza viruses use sialic acid as receptors for entering the host cells.&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
=== References  ===&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references /&amp;gt;&amp;lt;references /&amp;gt;&amp;lt;references /&amp;gt;&lt;/div&gt;</summary>
		<author><name>170109781</name></author>
	</entry>
	<entry>
		<id>https://teaching.ncl.ac.uk/bms/wiki//index.php?title=File:Structure_of_oseltamivir.png&amp;diff=19554</id>
		<title>File:Structure of oseltamivir.png</title>
		<link rel="alternate" type="text/html" href="https://teaching.ncl.ac.uk/bms/wiki//index.php?title=File:Structure_of_oseltamivir.png&amp;diff=19554"/>
		<updated>2017-12-04T23:55:35Z</updated>

		<summary type="html">&lt;p&gt;170109781: Structure of oseltamivir&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Structure of oseltamivir&lt;/div&gt;</summary>
		<author><name>170109781</name></author>
	</entry>
</feed>